Cargando…
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
BACKGROUND: In the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, a third of patients did not achieve remission or adequate response after two treatment trials, fulfilling requirements for treatment resistant depression (TRD). The present study is a secondary analysis of the...
Autores principales: | DiBernardo, Allitia, Lin, Xiwu, Zhang, Qiaoyi, Xiang, Jim, Lu, Lang, Jamieson, Carol, Benson, Carmela, Lee, Kwan, Bodén, Robert, Brandt, Lena, Brenner, Philip, Reutfors, Johan, Li, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206859/ https://www.ncbi.nlm.nih.gov/pubmed/30373547 http://dx.doi.org/10.1186/s12888-018-1920-7 |
Ejemplares similares
-
Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study
por: Brenner, Philip, et al.
Publicado: (2019) -
Substance use disorders and risk for treatment resistant depression: a population‐based, nested case‐control study
por: Brenner, Philip, et al.
Publicado: (2019) -
A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions
por: Hägg, David, et al.
Publicado: (2020) -
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
por: Li, Gang, et al.
Publicado: (2019) -
A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)